Association between age and survival in a cohort of Brazilian patients with operable breast cancer

Detalhes bibliográficos
Autor(a) principal: Débora Balabram
Data de Publicação: 2015
Outros Autores: Cassio M. Turra, Helenice Gobbi
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901
Resumo: Whether age is an independent prognostic factor in breast cancer is a matter of debate. This is a retrospective cohort study of 767 breast cancer patients, stages I-III, treated at the Hospital das Clínicas, Minas Gerais Federal University, Belo Horizonte, Minas Gerais State, Brazil, from 2001 to 2008, aiming to study the relationship between age and survival. We included variables related to patients, tumors, and types of treatment. Different sets of Cox models were used for survival analysis. Hazard ratios (HR) and 95%CI were calculated. The relationship between age and breast cancer survival did not change substantially in any of them. In the model that accounted for all variables, women aged 70 and older (HR = 1.51, 95%CI: 1.04-2.18), and 35 or younger (HR = 1.78, 95%CI: 1.05-3.01) had shorter cancer specific survival than patients aged between 36 and 69. In addition, older age, having at least one comorbidity, and being white were associated with a higher risk of dying from other causes. In conclusion, shorter breast cancer survival is expected among the youngest and oldest patients.
id FIOCRUZ-5_cec6fcffacfb5eb5ef242d1c7704d319
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/5901
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Association between age and survival in a cohort of Brazilian patients with operable breast cancerNeoplasm StagingEthnicity and HealthAge FactorsBreast NeoplasmsWhether age is an independent prognostic factor in breast cancer is a matter of debate. This is a retrospective cohort study of 767 breast cancer patients, stages I-III, treated at the Hospital das Clínicas, Minas Gerais Federal University, Belo Horizonte, Minas Gerais State, Brazil, from 2001 to 2008, aiming to study the relationship between age and survival. We included variables related to patients, tumors, and types of treatment. Different sets of Cox models were used for survival analysis. Hazard ratios (HR) and 95%CI were calculated. The relationship between age and breast cancer survival did not change substantially in any of them. In the model that accounted for all variables, women aged 70 and older (HR = 1.51, 95%CI: 1.04-2.18), and 35 or younger (HR = 1.78, 95%CI: 1.05-3.01) had shorter cancer specific survival than patients aged between 36 and 69. In addition, older age, having at least one comorbidity, and being white were associated with a higher risk of dying from other causes. In conclusion, shorter breast cancer survival is expected among the youngest and oldest patients.Es discutible si la edad es un factor pronóstico independiente para el cáncer de mama. Se realizó sobre una cohorte retrospectiva de 767 pacientes con cáncer de mama, etapas I-III, atendidas en el Hospital de Clínicas, Universidad Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil, entre 2001 y 2008, para estudiar la relación entre edad y supervivencia. Incluimos variables relacionadas con las pacientes, los tumores y el tratamiento. Se construyeron diferentes conjuntos de modelos de Cox. Se calcularon los cocientes de riesgo (CR) e IC95%. La relación entre edad y supervivencia del cáncer de mama no ha cambiado substancialmente en los modelos. En el modelo con todas las variables, las mujeres de 70 años o más (CR = 1,51; IC95%: 1,04-2,18) y 35 años o menos (CR = 1,78; IC95%: 1,05-3,01) tuvieron menor supervivencia por cáncer de mama que las de 36 a 69 años. Tener edad avanzada, al menos una comorbilidad, y ser de piel blanca se asociaron a un mayor riesgo de morir por otras causas. En conclusión, las mujeres más jóvenes y las mayores parecen tener menor supervivencia de cáncer de mama.É discutível se idade é um fator prognóstico independente para câncer de mama. Conduzimos uma coorte retrospectiva de 767 pacientes com câncer de mama, estádios I-III, tratadas no Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil, de 2001 a 2008, para estudar a relação entre idade e sobrevida. Incluímos variáveis relacionadas às pacientes, aos tumores e ao tratamento. Diferentes conjuntos de modelos de Cox foram construídos. As razões de risco (RR) e IC95% foram calculados. A relação entre idade e sobrevida por câncer de mama não foi alterada substancialmente entre os modelos de Cox. No modelo com todas as variáveis explicativas, as mulheres de 70 anos ou mais (RR = 1,51; IC95%: 1,04-2,18) e até 35 anos (RR = 1,78; IC95%: 1,05-3,01) tiveram sobrevida causa-específica mais curta que as de 36-69 anos. Idades a partir de 70 anos, ter ao menos uma comorbidade e ser branca foram associadas a risco maior de óbito por outras causas. Em conclusão, as pacientes mais jovens e as mais idosas parecem ter sobrevida mais curta por câncer de mama.Reports in Public HealthCadernos de Saúde Pública2015-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901Reports in Public Health; Vol. 31 No. 8 (2015): AugustCadernos de Saúde Pública; v. 31 n. 8 (2015): Agosto1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZenghttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901/12363https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901/12364Débora BalabramCassio M. TurraHelenice Gobbiinfo:eu-repo/semantics/openAccess2024-03-06T15:29:01Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/5901Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:06:45.565953Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Association between age and survival in a cohort of Brazilian patients with operable breast cancer
title Association between age and survival in a cohort of Brazilian patients with operable breast cancer
spellingShingle Association between age and survival in a cohort of Brazilian patients with operable breast cancer
Débora Balabram
Neoplasm Staging
Ethnicity and Health
Age Factors
Breast Neoplasms
title_short Association between age and survival in a cohort of Brazilian patients with operable breast cancer
title_full Association between age and survival in a cohort of Brazilian patients with operable breast cancer
title_fullStr Association between age and survival in a cohort of Brazilian patients with operable breast cancer
title_full_unstemmed Association between age and survival in a cohort of Brazilian patients with operable breast cancer
title_sort Association between age and survival in a cohort of Brazilian patients with operable breast cancer
author Débora Balabram
author_facet Débora Balabram
Cassio M. Turra
Helenice Gobbi
author_role author
author2 Cassio M. Turra
Helenice Gobbi
author2_role author
author
dc.contributor.author.fl_str_mv Débora Balabram
Cassio M. Turra
Helenice Gobbi
dc.subject.por.fl_str_mv Neoplasm Staging
Ethnicity and Health
Age Factors
Breast Neoplasms
topic Neoplasm Staging
Ethnicity and Health
Age Factors
Breast Neoplasms
description Whether age is an independent prognostic factor in breast cancer is a matter of debate. This is a retrospective cohort study of 767 breast cancer patients, stages I-III, treated at the Hospital das Clínicas, Minas Gerais Federal University, Belo Horizonte, Minas Gerais State, Brazil, from 2001 to 2008, aiming to study the relationship between age and survival. We included variables related to patients, tumors, and types of treatment. Different sets of Cox models were used for survival analysis. Hazard ratios (HR) and 95%CI were calculated. The relationship between age and breast cancer survival did not change substantially in any of them. In the model that accounted for all variables, women aged 70 and older (HR = 1.51, 95%CI: 1.04-2.18), and 35 or younger (HR = 1.78, 95%CI: 1.05-3.01) had shorter cancer specific survival than patients aged between 36 and 69. In addition, older age, having at least one comorbidity, and being white were associated with a higher risk of dying from other causes. In conclusion, shorter breast cancer survival is expected among the youngest and oldest patients.
publishDate 2015
dc.date.none.fl_str_mv 2015-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901/12363
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/5901/12364
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 31 No. 8 (2015): August
Cadernos de Saúde Pública; v. 31 n. 8 (2015): Agosto
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943380133117952